Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases

References

• Pimpin L, Cortez-Pinto H, Negro F, et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718–735.
   PubMed Web of Science ®Google Scholar
• Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–171.
   PubMed Web of Science ®Google Scholar
• Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145–1159.
   PubMed Web of Science ®Google Scholar
• Leveille M, Estall JL. Mitochondrial dysfunction in the transition from NASH to HCC. Metabolites. 2019;9(10):233.
   PubMed Web of Science ®Google Scholar
• Li R, Toan S, Zhou S. Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease. Aging. 2020;12(7):6467–6485.
   PubMedGoogle Scholar
• Frey TG, Mannella CA. The internal structure of mitochondria. Trends Biochem Sci. 2000;25(7):319–324.
   PubMed Web of Science ®Google Scholar
• Guo R, Gu J, Zong S, et al. Structure and mechanism of mitochondrial electron transport chain. Biomed J. 2018;41(1):9–20.
   PubMed Web of Science ®Google Scholar
• Yang Y, Karakhanova S, Hartwig W, et al. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy. J Cell Physiol. 2016;231(12):2570–2581.
   PubMed Web of Science ®Google Scholar
• Osellame LD, Blacker TS, Duchen MR. Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab. 2012;26(6):711–723.
   PubMed Web of Science ®Google Scholar
• Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1–13.
   PubMed Web of Science ®Google Scholar
• Korge P, John SA, Calmettes G, et al. Reactive oxygen species production induced by pore opening in cardiac mitochondria: the role of complex II. J Biol Chem. 2017;292(24):9896–9905.
   PubMed Web of Science ®Google Scholar
• Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005;120(4):483–495.
   PubMed Web of Science ®Google Scholar
• Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48(2):158–167.
   PubMed Web of Science ®Google Scholar
• Holzerova E, Prokisch H. Mitochondria: much ado about nothing? How dangerous is reactive oxygen species production? Int J Biochem Cell Biol. 2015;63:16–20.
   PubMed Web of Science ®Google Scholar
• Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 1997;94(2):514–519.
   PubMed Web of Science ®Google Scholar
• Busch KB, Kowald A, Spelbrink JN. Quality matters: how does mitochondrial network dynamics and quality control impact on mtDNA integrity? Philos Trans R Soc Lond B Biol Sci. 2014;369(1646):20130442.
   PubMed Web of Science ®Google Scholar
• Bertero E, Maack C. Calcium signaling and reactive oxygen species in mitochondria. Circ Res. 2018;122(10):1460–1478.
   PubMed Web of Science ®Google Scholar
• Fu S, Yang L, Li P, et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature. 2011;473(7348):528–531.
   PubMed Web of Science ®Google Scholar
• Satapati S, Kucejova B, Duarte JA, et al. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J Clin Invest. 2016;126(4):1605.
   PubMed Web of Science ®Google Scholar
• Koliaki C, Szendroedi J, Kaul K, et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 2015;21(5):739–746.
   PubMed Web of Science ®Google Scholar
• Teodoro JS, Rolo AP, Duarte FV, et al. Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression. Mitochondrion. 2008;8(5–6):367–376.
   PubMed Web of Science ®Google Scholar
• Korenaga M, Okuda M, Otani K, et al. Mitochondrial dysfunction in hepatitis C. J Clin Gastroenterol. 2005;39(4):S162–S166.
   PubMed Web of Science ®Google Scholar
• Shehu AI, Ma X, Venkataramanan R. Mechanisms of drug-induced hepatotoxicity. Clin Liver Dis. 2017;21(1):35–54.
   PubMed Web of Science ®Google Scholar
• Pirola CJ, Garaycoechea M, Flichman D, et al. Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease. J Intern Med. 2021;289(1):84–96.
   PubMed Web of Science ®Google Scholar
• Yu T, Zheng E, Li Y, et al. Src-mediated Tyr353 phosphorylation of IP3R1 promotes its stability and causes apoptosis in palmitic acid-treated hepatocytes. Exp Cell Res. 2021;399(2):112438.
   PubMed Web of Science ®Google Scholar
• Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol. 2002;27(1):63–68.
   PubMed Web of Science ®Google Scholar
• Yin M, Gabele E, Wheeler MD, et al. Alcohol-induced free radicals in mice: direct toxicants or signaling molecules? Hepatology. 2001;34(5):935–942.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Xu MJ, Cai Y, et al. Neutrophil-hepatic stellate cell interactions promote fibrosis in experimental steatohepatitis. Cell Mol Gastroenterol Hepatol. 2018;5(3):399–413.
   PubMed Web of Science ®Google Scholar
• Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155(3):629–647.
   PubMed Web of Science ®Google Scholar
• Cai CC, Zhu JH, Ye LX, et al. Glycine protects against hypoxic-ischemic brain injury by regulating mitochondria-mediated autophagy via the AMPK pathway. Oxid Med Cell Longev. 2019;2019:4248529.
   PubMed Web of Science ®Google Scholar
• Zhao P, Sun X, Chaggan C, et al. An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science. 2020;367(6478):652–660.
   PubMed Web of Science ®Google Scholar
• Serviddio G, Bellanti F, Tamborra R, et al. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut. 2008;57(7):957–965.
   PubMed Web of Science ®Google Scholar
• Mantena SK, King AL, Andringa KK, et al. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med. 2008;44(7):1259–1272.
   PubMed Web of Science ®Google Scholar
• Herzig S, Raemy E, Montessuit S, et al. Identification and functional expression of the mitochondrial pyruvate carrier. Science. 2012;337(6090):93–96.
   PubMed Web of Science ®Google Scholar
• McCommis KS, Finck BN. Treating hepatic steatosis and fibrosis by modulating mitochondrial pyruvate metabolism. Cell Mol Gastroenterol Hepatol. 2019;7(2):275–284.
   PubMed Web of Science ®Google Scholar
• McCommis KS, Hodges WT, Brunt EM, et al. Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis. Hepatology. 2017;65(5):1543–1556.
   PubMed Web of Science ®Google Scholar
• Kato M, Li J, Chuang JL, et al. Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol. Structure. 2007;15(8):992–1004.
   PubMed Web of Science ®Google Scholar
• Green DR. Paradoxical puma prohibits pyruvate pumps to prime pathology. Cancer Cell. 2019;35(2):163–165.
   PubMed Web of Science ®Google Scholar
• Kim J, Yu L, Chen W, et al. Wild-type p53 promotes cancer metabolic switch by inducing PUMA-dependent suppression of oxidative phosphorylation. Cancer Cell. 2019;35(2):191–203.
   PubMed Web of Science ®Google Scholar
• da Silva RP, Eudy BJ, Deminice R. One-carbon metabolism in fatty liver disease and fibrosis: one-carbon to rule them all. J Nutr. 2020;150(5):994–1003.
   PubMed Web of Science ®Google Scholar
• Alonzo JR, Venkataraman C, Field MS, et al. The mitochondrial inner membrane protein MPV17 prevents uracil accumulation in mitochondrial DNA. J Biol Chem. 2018;293(52):20285–20294.
   PubMed Web of Science ®Google Scholar
• Morscher RJ, Ducker GS, Li SH, et al. Mitochondrial translation requires folate-dependent tRNA methylation. Nature. 2018;554(7690):128–132.
   PubMed Web of Science ®Google Scholar
• Sid V, Siow YL, O K. Role of folate in nonalcoholic fatty liver disease. Can J Physiol Pharmacol. 2017;95(10):1141–1148.
   PubMed Web of Science ®Google Scholar
• Wu X, Deng L, Tang D, et al. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma. Tumour Biol. 2016;37(5):6813–6821.
   PubMedGoogle Scholar
• Ji L, Tang Y, Pang X, et al. Increased expression of serine hydroxymethyltransferase 2 (SHMT2) is a negative prognostic marker in patients with hepatocellular carcinoma and is associated with proliferation of HepG2 cells. Med Sci Monit. 2019;25:5823–5832.
   PubMed Web of Science ®Google Scholar
• Yang M, Linn BS, Zhang Y, et al. Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury. Biochim Biophys Acta Mol Basis Dis. 2019;1865(9):2293–2302.
   PubMed Web of Science ®Google Scholar
• Cho HM, Sun W. Molecular cross talk among the components of the regulatory machinery of mitochondrial structure and quality control. Exp Mol Med. 2020;52(5):730–737.
   PubMed Web of Science ®Google Scholar
• Pernas L, Scorrano L. Mito-morphosis: mitochondrial fusion, fission, and cristae remodeling as key mediators of cellular function. Annu Rev Physiol. 2016;78:505–531.
   PubMed Web of Science ®Google Scholar
• Liu R, Chan DC. The mitochondrial fission receptor Mff selectively recruits oligomerized Drp1. Mol Biol Cell. 2015;26(24):4466–4477.
   PubMed Web of Science ®Google Scholar
• Loson OC, Song Z, Chen H, et al. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell. 2013;24(5):659–667.
   PubMed Web of Science ®Google Scholar
• Sebastian D, Hernandez-Alvarez MI, Segales J, et al. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci USA. 2012;109(14):5523–5528.
   PubMed Web of Science ®Google Scholar
• Hernandez-Alvarez MI, Sebastian D, Vives S, et al. Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease. Cell. 2019;177(4):881–895.
   PubMed Web of Science ®Google Scholar
• Vande Walle L, Lamkanfi M, Vandenabeele P. The mitochondrial serine protease HtrA2/Omi: an overview. Cell Death Differ. 2008;15(3):453–460.
   PubMed Web of Science ®Google Scholar
• Hur W, Kang BY, Kim SM, et al. Serine protease HtrA2/Omi deficiency impairs mitochondrial homeostasis and promotes hepatic fibrogenesis via activation of hepatic stellate cells. Cells. 2019;8(10):1119.
   PubMed Web of Science ®Google Scholar
• Goo HG, Jung MK, Han SS, et al. HtrA2/Omi deficiency causes damage and mutation of mitochondrial DNA. Biochim Biophys Acta. 2013;1833(8):1866–1875.
   PubMed Web of Science ®Google Scholar
• Ding WX, Yin XM. Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol Chem. 2012;393(7):547–564.
   PubMed Web of Science ®Google Scholar
• Ke PY. Mitophagy in the pathogenesis of liver diseases. Cells. 2020;9(4):831.
   Web of Science ®Google Scholar
• Bingol B, Sheng M. Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond. Free Radic Biol Med. 2016;100:210–222.
   PubMed Web of Science ®Google Scholar
• Buhlman L, Damiano M, Bertolin G, et al. Functional interplay between Parkin and Drp1 in mitochondrial fission and clearance. Biochim Biophys Acta. 2014;1843(9):2012–2026.
   PubMed Web of Science ®Google Scholar
• Peng H, Qin X, Chen S, et al. Parkin deficiency accentuates chronic alcohol intake-induced tissue injury and autophagy defects in brain, liver and skeletal muscle. Acta Biochim Biophys Sin. 2020;52(6):665–674.
   Google Scholar
• Wang H, Ni HM, Chao X, et al. Double deletion of PINK1 and Parkin impairs hepatic mitophagy and exacerbates acetaminophen-induced liver injury in mice. Redox Biol. 2019;22:101148.
   PubMed Web of Science ®Google Scholar
• Campbell CT, Kolesar JE, Kaufman BA. Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim Biophys Acta. 2012;1819(9–10):921–929.
   PubMed Web of Science ®Google Scholar
• Aharoni-Simon M, Hann-Obercyger M, Pen S, et al. Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice. Lab Invest. 2011;91(7):1018–1028.
   PubMed Web of Science ®Google Scholar
• Arduini A, Serviddio G, Escobar J, et al. Mitochondrial biogenesis fails in secondary biliary cirrhosis in rats leading to mitochondrial DNA depletion and deletions. Am J Physiol Gastrointest Liver Physiol. 2011;301(1):G119–G127.
   PubMed Web of Science ®Google Scholar
• Serviddio G, Bellanti F, Stanca E, et al. Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis. Free Radic Biol Med. 2014;73:117–126.
   PubMed Web of Science ®Google Scholar
• Du K, Ramachandran A, McGill MR, et al. Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity. Food Chem Toxicol. 2017;108(A):339–350.
   PubMedGoogle Scholar
• Kang JW, Hong JM, Lee SM. Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis. J Pineal Res. 2016;60(4):383–393.
   PubMed Web of Science ®Google Scholar
• Panel M, Ghaleh B, Morin D. Mitochondria and aging: a role for the mitochondrial transition pore? Aging Cell. 2018;17(4):e12793.
   PubMed Web of Science ®Google Scholar
• Karch J, Bround MJ, Khalil H, et al. Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. Sci Adv. 2019;5(8):eaaw4597.
   PubMed Web of Science ®Google Scholar
• Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28(4):370–379.
   PubMed Web of Science ®Google Scholar
• Chowdhury A, Santra A, Bhattacharjee K, et al. Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice. J Hepatol. 2006;45(1):117–126.
   PubMed Web of Science ®Google Scholar
• Panel M, Ruiz I, Brillet R, et al. Small-molecule inhibitors of cyclophilins block opening of the mitochondrial permeability transition pore and protect mice from hepatic ischemia/reperfusion injury. Gastroenterology. 2019;157(5):1368–1382.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Qu H, Xiong X, et al. Deficiency of mitochondrial glycerol 3-phosphate dehydrogenase contributes to hepatic steatosis. Hepatology. 2019;70(1):84–97.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Liu J, Deng H, et al. Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output. Cell. 2020;183(1):76–93.
   PubMed Web of Science ®Google Scholar
• Boyapati RK, Tamborska A, Dorward DA, et al. Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res. 2017;6:169.
   PubMedGoogle Scholar
• Malik AN, Simoes ICM, Rosa HS, et al. A diet induced maladaptive increase in hepatic mitochondrial DNA precedes OXPHOS defects and may contribute to non-alcoholic fatty liver disease. Cells. 2019;8(10):1222.
   Web of Science ®Google Scholar
• Marques PE, Oliveira AG, Pereira RV, et al. Hepatic DNA deposition drives drug-induced liver injury and inflammation in mice. Hepatology. 2015;61(1):348–360.
   PubMed Web of Science ®Google Scholar
• An P, Wei LL, Zhao S, et al. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nat Commun. 2020;11(1):2362.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104–107.
   PubMed Web of Science ®Google Scholar
• Garcia-Martinez I, Santoro N, Chen Y, et al. Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest. 2016;126(3):859–864.
   PubMed Web of Science ®Google Scholar
• Handa P, Vemulakonda A, Kowdley KV, et al. Mitochondrial DNA from hepatocytes as a ligand for TLR9: drivers of nonalcoholic steatohepatitis? World J Gastroenterol. 2016;22(31):6965–6971.
   PubMed Web of Science ®Google Scholar
• Pan J, Ou Z, Cai C, et al. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release. Cell Immunol. 2018;332:111–120.
   PubMed Web of Science ®Google Scholar
• Lee JH, Shim YR, Seo W, et al. Mitochondrial double-stranded RNA in exosome promotes interleukin-17 production through toll-like receptor 3 in alcoholic liver injury. Hepatology. 2020;72(2):609–625.
   PubMed Web of Science ®Google Scholar
• Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med. 2015;88(B):314–336.
   PubMedGoogle Scholar
• Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004;10(11):549–557.
   PubMed Web of Science ®Google Scholar
• Lee DH, Park JS, Lee YS, et al. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity. Autophagy. 2020;16(11):1949–1973.
   PubMed Web of Science ®Google Scholar
• Lee DH, Jung YY, Park MH, et al. Peroxiredoxin 6 confers protection against nonalcoholic fatty liver disease through maintaining mitochondrial function. Antioxid Redox Signal. 2019;31(5):387–402.
   PubMed Web of Science ®Google Scholar
• Tan Y, Jin Y, Wang Q, et al. Perilipin 5 protects against cellular oxidative stress by enhancing mitochondrial function in HepG2 cells. Cells. 2019;8(10)1241.
   PubMed Web of Science ®Google Scholar
• Keenan SN, Meex RC, Lo JCY, et al. Perilipin 5 deletion in hepatocytes remodels lipid metabolism and causes hepatic insulin resistance in mice. Diabetes. 2019;68(3):543–555.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang Z, Feng D, et al. p66Shc contributes to liver fibrosis through the regulation of mitochondrial reactive oxygen species. Theranostics. 2019;9(5):1510–1522.
   PubMed Web of Science ®Google Scholar
• Wojtalla A, Herweck F, Granzow M, et al. The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes. Am J Physiol Gastrointest Liver Physiol. 2012;302(8):G873–G887.
   PubMed Web of Science ®Google Scholar
• Siegmund SV, Qian T, de Minicis S, et al. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J. 2007;21(11):2798–2806.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Horvath B, Rajesh M, et al. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. J Hepatol. 2017;66(3):589–600.
   PubMed Web of Science ®Google Scholar
• Jacobi D, Liu S, Burkewitz K, et al. Hepatic Bmal1 regulates rhythmic mitochondrial dynamics and promotes metabolic fitness. Cell Metab. 2015;22(4):709–720.
   PubMed Web of Science ®Google Scholar
• Zhang T, Gu J, Guo J, et al. Renalase attenuates mouse fatty liver ischemia/reperfusion injury through mitigating oxidative stress and mitochondrial damage via activating SIRT1. Oxid Med Cell Longev. 2019;2019:7534285.
   PubMed Web of Science ®Google Scholar
• Hao L, Sun Q, Zhong W, et al. Mitochondria-targeted ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of aldehyde dehydrogenase 2: a molecular mechanism of protection against alcoholic liver disease. Redox Biol. 2018;14:626–636.
   PubMed Web of Science ®Google Scholar
• Vilaseca M, Garcia-Caldero H, Lafoz E, et al. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats. Liver Int. 2017;37(7):1002–1012.
   PubMed Web of Science ®Google Scholar
• Li G, Chan YL, Sukjamnong S, et al. A mitochondrial specific antioxidant reverses metabolic dysfunction and fatty liver induced by maternal cigarette smoke in mice. Nutrients. 2019;11(7):1669.
   Web of Science ®Google Scholar
• Lu SC, Mato JM. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev. 2012;92(4):1515–1542.
   PubMed Web of Science ®Google Scholar
• King AL, Mantena SK, Andringa KK, et al. The methyl donor S-adenosylmethionine prevents liver hypoxia and dysregulation of mitochondrial bioenergetic function in a rat model of alcohol-induced fatty liver disease. Redox Biol. 2016;9:188–197.
   PubMed Web of Science ®Google Scholar
• Xin X, Chen C, Hu YY, et al. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD). Biomed Pharmacother. 2019;117:109047.
   PubMed Web of Science ®Google Scholar
• Salic K, Gart E, Seidel F, et al. Combined treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity and liver steatosis. Int J Mol Sci. 2019;20(18):4359.
   Web of Science ®Google Scholar
• Wang EY, Gang H, Aviv Y, et al. p53 mediates autophagy and cell death by a mechanism contingent on Bnip3. Hypertension. 2013;62(1):70–77.
   PubMed Web of Science ®Google Scholar
• Zhao B-x, Chen H-z, Du X-d, et al. Orphan receptor TR3 enhances p53 transactivation and represses DNA double-strand break repair in hepatoma cells under ionizing radiation. Mol Endocrinol. 2011;25(8):1337–1350.
   PubMedGoogle Scholar
• Zhou H, Du W, Li Y, et al. Effects of melatonin on fatty liver disease: the role of NR4A1/DNA-PKcs/p53 pathway, mitochondrial fission, and mitophagy. J Pineal Res. 2018;64(1):12450.
   Web of Science ®Google Scholar
• Zhou H, Zhu P, Wang J, et al. DNA-PKcs promotes alcohol-related liver disease by activating Drp1-related mitochondrial fission and repressing FUNDC1-required mitophagy. Signal Transduct Target Ther. 2019;4:56.
   PubMed Web of Science ®Google Scholar
• Ding M, Feng N, Tang D, et al. Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1α pathway. J Pineal Res. 2018;65(2):e12491.
   PubMed Web of Science ®Google Scholar
• Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal. 2009;7:e003.
   PubMedGoogle Scholar
• Kim HJ, Han YH, Na H, et al. Liver-specific deletion of RORα aggravates diet-induced nonalcoholic steatohepatitis by inducing mitochondrial dysfunction. Sci Rep. 2017;7(1):16041.
   PubMedGoogle Scholar
• Deng XH, Liu JJ, Sun XJ, et al. Benzoylaconine induces mitochondrial biogenesis in mice via activating AMPK signaling cascade. Acta Pharmacol Sin. 2019;40(5):658–665.
   PubMed Web of Science ®Google Scholar
• Song P, Kwon Y, Yea K, et al. Apolipoprotein a1 increases mitochondrial biogenesis through AMP-activated protein kinase. Cell Signal. 2015;27(9):1873–1881.
   PubMed Web of Science ®Google Scholar
• Rai PK, Russell OM, Lightowlers RN, et al. Potential compounds for the treatment of mitochondrial disease. Br Med Bull. 2015;116:5–18.
   PubMed Web of Science ®Google Scholar
• Kang JW, Choi HS, Lee SM. Resolvin D1 attenuates liver ischaemia/reperfusion injury through modulating thioredoxin 2-mediated mitochondrial quality control. Br J Pharmacol. 2018;175(12):2441–2453.
   PubMed Web of Science ®Google Scholar
• Bi J, Zhang J, Ren Y, et al. Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress. Redox Biol. 2019;20:296–306.
   PubMed Web of Science ®Google Scholar
• Civiletto G, Dogan SA, Cerutti R, et al. Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis. EMBO Mol Med. 2018;10(11):e8799.
   PubMed Web of Science ®Google Scholar
• Du H, Guo L, Fang F, et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease. Nat Med. 2008;14(10):1097–1105.
   PubMed Web of Science ®Google Scholar
• Devalaraja-Narashimha K, Diener AM, Padanilam BJ. Cyclophilin D deficiency prevents diet-induced obesity in mice. FEBS Lett. 2011;585(4):677–682.
   PubMed Web of Science ®Google Scholar
• Wang X, Du H, Shao S, et al. Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis. Hepatology. 2018;68(1):62–77.
   PubMed Web of Science ®Google Scholar
• Guo L, Du H, Yan S, et al. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer’s neurons. PLoS One. 2013;8(1):e54914.
   PubMed Web of Science ®Google Scholar
• Mishra J, Davani AJ, Stowe DF, et al. Cyclosporin A: new insights into its potential role in mitochondrial calcium buffering. Biophys J. 2018;114(3):659a.
   Web of Science ®Google Scholar
• Yin X, Zheng F, Pan Q, et al. Glucose fluctuation increased hepatocyte apoptosis under lipotoxicity and the involvement of mitochondrial permeability transition opening. J Mol Endocrinol. 2015;55(3):169–181.
   PubMed Web of Science ®Google Scholar
• Waldmeier PC, Feldtrauer JJ, Qian T, et al. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol Pharmacol. 2002;62(1):22–29.
   PubMed Web of Science ®Google Scholar
• Watashi K, Hijikata M, Hosaka M, et al. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology. 2003;38(5):1282–1288.
   PubMed Web of Science ®Google Scholar
• Kohjima M, Enjoji M, Higuchi N, et al. NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. Liver Int. 2007;27(9):1273–1281.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang Y, Wang T, et al. N-methyl-4-isoleucine cyclosporine attenuates CCl -induced liver fibrosis in rats by interacting with cyclophilin B and D. J Gastroenterol Hepatol. 2011;26(3):558–567.
   PubMed Web of Science ®Google Scholar
• Brenner C, Moulin M. Physiological roles of the permeability transition pore. Circ Res. 2012;111(9):1237–1247.
   PubMed Web of Science ®Google Scholar
• Goncalves IO, Passos E, Diogo CV, et al. Exercise mitigates mitochondrial permeability transition pore and quality control mechanisms alterations in nonalcoholic steatohepatitis. Appl Physiol Nutr Metab. 2016;41(3):298–306.
   PubMed Web of Science ®Google Scholar
• Gollihue JL, Rabchevsky AG. Prospects for therapeutic mitochondrial transplantation. Mitochondrion. 2017;35:70–79.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ito M, Arai M, et al. Challenges in promoting mitochondrial transplantation therapy. Int J Mol Sci. 2020;21(17):6365.
   PubMed Web of Science ®Google Scholar
• Lin HC, Liu SY, Lai HS, et al. Isolated mitochondria infusion mitigates ischemia-reperfusion injury of the liver in rats. Shock. 2013;39(3):304–310.
   PubMed Web of Science ®Google Scholar
• Fu A, Shi X, Zhang H, et al. Mitotherapy for fatty liver by intravenous administration of exogenous mitochondria in male mice. Front Pharmacol. 2017;8:241.
   PubMed Web of Science ®Google Scholar
• Gane EJ, Weilert F, Orr DW, et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int. 2010;30(7):1019–1026.
   PubMed Web of Science ®Google Scholar
• Hong M, Li S, Tan HY, et al. Current status of herbal medicines in chronic liver disease therapy: the biological effects, molecular targets and future prospects. Int J Mol Sci. 2015;16(12):28705–28745.
   PubMed Web of Science ®Google Scholar
• Xu L, Nagata N, Ota T. Impact of glucoraphanin-mediated activation of Nrf2 on non-alcoholic fatty liver disease with a focus on mitochondrial dysfunction. Int J Mol Sci. 2019;20(23):5920.
   Web of Science ®Google Scholar
• Zhou R, Lin J, Wu D. Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis. Biochim Biophys Acta. 2014;1840(1):209–218.
   PubMed Web of Science ®Google Scholar
• Kubo E, Chhunchha B, Singh P, et al. Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress. Sci Rep. 2017;7(1):14130.
   PubMedGoogle Scholar
• Zhang R, Chu K, Zhao N, et al. Corilagin alleviates nonalcoholic fatty liver disease in high-fat diet-induced C57BL/6 mice by ameliorating oxidative stress and restoring autophagic flux. Front Pharmacol. 2019;10:1693.
   PubMed Web of Science ®Google Scholar
• Ming Y, Zheng Z, Chen L, et al. Corilagin inhibits hepatocellular carcinoma cell proliferation by inducing G2/M phase arrest. Cell Biol Int. 2013;37(10):1046–1054.
   PubMed Web of Science ®Google Scholar
• Liu FC, Chaudry IH, Yu HP. Hepatoprotective effects of corilagin following hemorrhagic shock are through Akt-dependent pathway. Shock. 2017;47(3):346–351.
   PubMed Web of Science ®Google Scholar
• Reddy BU, Mullick R, Kumar A, et al. A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage. Antiviral Res. 2018;150:47–59.
   PubMed Web of Science ®Google Scholar
• Galvano F, La Fauci L, Lazzarino G, et al. Cyanidins: metabolism and biological properties. J Nutr Biochem. 2004;15(1):2–11.
   PubMed Web of Science ®Google Scholar
• Li X, Shi Z, Zhu Y, et al. Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice. Br J Pharmacol. 2020;177(15):3591–3607.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun Y, Zang Y, et al. GanMeijian ameliorates lipid accumulation and oxidative damage in alcoholic fatty liver disease in Wistar rats. Life Sci. 2020;255:117721.
   PubMed Web of Science ®Google Scholar
• Zhang P, Qiang X, Zhang M, et al. Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver disease mouse model. J Pharmacol Exp Ther. 2015;352(1):139–147.
   PubMed Web of Science ®Google Scholar
• Wang F, Jia Y, Li M, et al. Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells. Cell Commun Signal. 2019;17(1):11.
   PubMedGoogle Scholar
• Jin H, Lian N, Bian M, et al. Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha. Chem Biol Interact. 2018;285:14–20.
   PubMed Web of Science ®Google Scholar
• Kai J, Yang X, Wang Z, et al. Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. Free Radic Biol Med. 2020;153:89–102.
   PubMed Web of Science ®Google Scholar
• Tiwari H, Rao MV. Curcumin supplementation protects from genotoxic effects of arsenic and fluoride. Food Chem Toxicol. 2010;48(5):1234–1238.
   PubMed Web of Science ®Google Scholar
• Wang B, Gao X, Liu B, et al. Protective effects of curcumin against chronic alcohol-induced liver injury in mice through modulating mitochondrial dysfunction and inhibiting endoplasmic reticulum stress. Food Nutr Res. 2019;63:3567.
   Web of Science ®Google Scholar
• Tan X, Li L, Wang J, et al. Resveratrol prevents acrylamide-induced mitochondrial dysfunction and inflammatory responses via targeting circadian regulator Bmal1 and Cry1 in hepatocytes. J Agric Food Chem. 2019;67(31):8510–8519.
   PubMed Web of Science ®Google Scholar
• Park SM, Lee JR, Ku SK, et al. Isoliquiritigenin in licorice functions as a hepatic protectant by induction of antioxidant genes through extracellular signal-regulated kinase-mediated NF-E2-related factor-2 signaling pathway. Eur J Nutr. 2016;55(8):2431–2444.
   PubMed Web of Science ®Google Scholar
• Qin H, Zhang LL, Xiong XL, et al. Li-Dan-He-Ji improves infantile cholestasis hepatopathy through inhibiting calcium-sensing receptor-mediated hepatocyte apoptosis. Front Pharmacol. 2020;11:156.
   PubMed Web of Science ®Google Scholar
• Mogalli R, Matsukawa T, Shimomura O, et al. Cyanidin-3-glucoside enhances mitochondrial function and biogenesis in a human hepatocyte cell line. Cytotechnology. 2018;70(6):1519–1528.
   PubMed Web of Science ®Google Scholar
• Fernández-Checa J, Hirano T, Tsukamoto H, et al. Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol. 1993;10(6):469–475.
   PubMed Web of Science ®Google Scholar
• Pessayre D, Fromenty B, Berson A, et al. Central role of mitochondria in drug-induced liver injury. Drug Metab Rev. 2012;44(1):34–87.
   PubMed Web of Science ®Google Scholar
• Katayama T, Kinugawa S, Takada S, et al. A mitochondrial delivery system using liposome-based nanocarriers that target myoblast cells. Mitochondrion. 2019;49:66–72.
   PubMed Web of Science ®Google Scholar